NCT06278766View on ClinicalTrials.gov

A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 21, 2024

Primary Completion Date

April 19, 2024

Study Completion Date

April 19, 2024

Conditions
Healthy Volunteer
Interventions
DRUG

ABBV-552

Oral Solution

Trial Locations (1)

53704

Fortrea Clinical Research Unit Inc /ID# 262684, Madison

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY

NCT06278766 - A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose Administration | Biotech Hunter | Biotech Hunter